Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Exclusive: Cigna seeks sale of group benefits insurance business - sources

Published 08/20/2019, 11:31 AM
Updated 08/20/2019, 11:31 AM
© Reuters. A screen displays the logo fro Cigna Corp. on the floor at the NYSE in New York

© Reuters. A screen displays the logo fro Cigna Corp. on the floor at the NYSE in New York

By David French

(Reuters) - U.S. health insurer Cigna Corp (NYSE:CI) is exploring a sale of its group benefits insurance business, which could be valued at as much as $6 billion, four people familiar with the matter said on Tuesday.

The unit for sale offers disability insurance as well as life and accidental death and dismemberment coverage to clusters of company employees. Cigna's move to shed it underscores its decision to focus on healthcare following its $54-billion acquisition of pharmacy benefits manager Express Scripts (NASDAQ:ESRX) Holding Co last year.

The Bloomfield, Connecticut-based company is working with an investment bank to run an auction for the group benefits business, the sources said. The unit could attract interest from other insurers that already have this product line and are seeking scale in that competitive market, the sources added.

While stating the company does not comment on rumors and speculation, a Cigna spokesman said: "Given the dynamic marketplace, we continually review opportunities to ensure we continue to deliver value to our customers and clients."

The sources asked not to be identified because the matter is confidential.

Cigna's group benefits business sits within the company's group disability and other operations division. This unit reported $1.31 billion of adjusted revenue in the three months to June 30, and covered 15.4 million people as of that date, according to Cigna's second-quarter financial statement.

Other health insurers have carried out similar divestitures. Aetna Inc (NYSE:AET) announced in October 2017 that it would sell its U.S. group life and disability unit for $1.45 billion to Hartford Financial Services Group (NYSE:HIG).

As health insurers face regulatory uncertainty amid political efforts to lower U.S. healthcare costs ahead of the 2020 presidential election, Cigna is hoping the acquisition of Express Scripts will help rein in its own costs.

That deal put Cigna in direct competition with CVS Health Corp (NYSE:CVS), which acquired Aetna last year, as well as UnitedHealth Group Inc (NYSE:UNH) and its pharmacy benefit manager Optum.

© Reuters. A screen displays the logo fro Cigna Corp. on the floor at the NYSE in New York

Any proceeds from the sale of its group benefits insurance business could help Cigna pay down its long-term debt, which totaled $37 billion as of the end of June.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.